Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Licensing revenue
Expenses:
Research and development	593,784		624,080
General and administrative	700,784	1,021,166	1,502,386	2,101,204
Loss from operations	(1,294,568)	(1,021,166)	(2,126,466)	(2,101,204)
Other income:
Interest income	11,581	2,831	30,213	7,098
Sale of royalty and milestone rights, net of transaction costs		4,167,219	1,000,000	4,167,219
Other income, net		82		1,355
Net income (loss)	(1,282,987)	3,148,966	(1,096,253)	2,074,468
Dividends paid on preferred shares				(68,809)
Net income (loss) attributable to common stockholders	$ (1,282,987)	$ 3,148,966	$ (1,096,253)	$ 2,005,659
Total basic income (loss) per share	$ (2.59)	$ 6.45	$ (2.21)	$ 4.31
Total diluted income (loss) per share	$ (2.59)	$ 6.45	$ (2.21)	$ 4.31
Basic weighted-average shares outstanding	495,092	488,398	495,092	481,142
Diluted weighted-average shares outstanding	495,092	488,398	495,092	481,142